MoU Between the CSIR, DBT and ICMR signed on December 31st,2018.
A inter-ministerial tripartite Memorandum of Understanding (MoU) was signed between the Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR) on December 31st, 2018.
The MoU amongst CSIR, DBT and ICMR is for cooperation for the promotion and facilitation of innovative research on phytopharmaceuticals. The three agencies have mutually agreed to collaboratively develop phytopharmaceutical products for therapeutic uses following international standards and norms for establishing safety, quality, standardization and efficacy. The effort would be to take forward the leads already existing with CSIR, DBT and ICMR and develop specific collaborative projects in the domain aiming at rigorous modern scientific testing and development of standard products to maintain global competitiveness.
The role of each party has been defined in the MoU. CSIR will be responsible for proposing leads (both with short term & long term translational period), which can be taken forward for phytopharmaceutical product development following DCGI regulatory guidelines; pre-clinical pharmacology; CMC and IND enabling studies; and safety and regulatory toxicity studies. DBT would be responsible for proposing leads based on its extra-mural research, providing funds for R&D projects taken under the MoU and preparation of respective sections of IND dossier in mutual collaboration with ICMR. Preparation of IND dossier and its submission to DCGI, preparation of clinical trials protocols, obtaining regulatory clearance for clinical trials and conducting trials with compilation of results etc. would be the responsibility of ICMR.
 |
MoU between ICMR and Emami Limited for developing a Phytopharmaceutical product in the area of Pre-diabetes on 12th May, 2019
The Memorandum of Understanding (MoU) was signed between the Indian Council of Medical Research (ICMR) and Emami Limited Kolkata on 12th May, 2019. The MoU is for developing a Phytopharmaceutical product following regulatory guidelines and national and international standards and norms for establishing safety, quality and standardization in the area of pre-diabetes.
 |
MoU between ICMR and Emami Limited for developing an Ayurvedic product in the area of Sleep disorders on 12th May, 2019
The Memorandum of Understanding (MoU) was signed between the Indian Council of Medical Research (ICMR) and Emami Limited Kolkata on 12th May, 2019. The MoU is for collaboratively developing an Ayurvedic product following international standards and norms for establishing safety, quality, standardization and efficacy for treatment of sleep disorder.
 |
MoU between ICMR and Pharmacopoeal Commission of Indian Medicine (PCIM) on 10th April, 2015
A MoU between ICMR and Pharmacopoeal Commission of Indian Medicine(PCIM), Ministry of Ayush was signed on 10.4.2015 under which 120 PRS generated through extramural projects of ICMR were transferred to PCIM along with all spectral data for characterization and Quality Assurance of Ayurveda, Siddha & Unani Drugs (ASU) drugs. This will lead to wider acceptance of Traditional Medicines in India and abroad, as quality assurance is the key issue.
 |